White Guide and Orange Guide Formatting Project - Pfizer

Orange Guide – Chapter 6: Clinical Research and Investigator-Initiated Research
You may never commit to hiring an HCP as an investigator or make any other promises relating to the
hiring of an HCP as an investigator. All decisions about clinical investigators must be made by the
Pfizer Medical Division.
For guidance on responding to HCP questions about participation in Pfizer-sponsored research or
clinical trials, see the section titled “Responding to Requests from HCPs Regarding Medical Research”
found later in this chapter.
Clinical Studies and Prescribing Habits
Q. A very influential physician is reluctant to prescribe a certain Pfizer product.
Can I recommend to my Regional Medical Research Specialist (RMRS) that this
physician be selected as an investigator in an upcoming clinical trial for that
product so that he can gain additional first-hand experience on the product’s
use?
A. No. You may not recommend a physician to be an investigator if a purpose for
choosing the physician is to influence prescribing habits. Investigators must be
selected solely on their research experience and clinical training, not on their
current or future prescribing habits.
Investigator-Initiated Research Grants
Pfizer provides support to investigators, institutions or organizations (e.g., cooperative groups,
government agencies, or networks) that sponsor studies that advance medical and scientific knowledge
and are of interest to Pfizer. These grants may be in the form of money, study medication or pure
substance. Pfizer may not design, conduct, or supervise IIR studies. Rather, they must be conducted
independent of any influence or guidance by Pfizer. The evaluation of an IIR request cannot be
influenced by an investigator’s, institution’s or organization’s generation of past or potential future
business for Pfizer or any decisions the investigator or institution has made or may make in the future
related to Pfizer or Pfizer products
All proposals for an IIR grant must be referred to your RMRS or Asset Team Medical Colleague, who will
ensure that the proposal is submitted through the application website at www.pfizer.com/iir
(as required by CMCD CT25). Such proposals will then receive requisite medical evaluation. Because IIR
support could potentially influence prescribing patterns, the decision to fund an IIR study must be made
118
Rev. 09/12
Page 5 of 9